BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $92,106 | -6.3% | 30,298 | +1.4% | 0.00% | 0.0% |
| Q2 2023 | $98,295 | +3.6% | 29,877 | +0.2% | 0.00% | 0.0% |
| Q1 2023 | $94,834 | -37.0% | 29,822 | +37.0% | 0.00% | 0.0% |
| Q4 2022 | $150,593 | +63.7% | 21,762 | +14.8% | 0.00% | 0.0% |
| Q1 2022 | $92,000 | -49.5% | 18,951 | +4.2% | 0.00% | 0.0% |
| Q4 2021 | $182,000 | -48.1% | 18,189 | -1.0% | 0.00% | -66.7% |
| Q3 2021 | $351,000 | -39.9% | 18,372 | +0.7% | 0.00% | -40.0% |
| Q2 2021 | $584,000 | +0.2% | 18,251 | -5.5% | 0.01% | 0.0% |
| Q1 2021 | $583,000 | -29.8% | 19,321 | +0.6% | 0.01% | -37.5% |
| Q4 2020 | $831,000 | -21.2% | 19,205 | -1.7% | 0.01% | -20.0% |
| Q3 2020 | $1,054,000 | +18.3% | 19,535 | +33.8% | 0.01% | -23.1% |
| Q2 2020 | $891,000 | +49.2% | 14,604 | +12.4% | 0.01% | +30.0% |
| Q1 2020 | $597,000 | – | 12,990 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 6,335,528 | $40,104,000 | 4.92% |
| qPULA Trading Management LP | 14,344 | $91,000 | 0.80% |
| Frazier Life Sciences Management, L.P. | 1,440,757 | $9,120,000 | 0.70% |
| Ikarian Capital, LLC | 462,628 | $2,928,000 | 0.58% |
| Birchview Capital, LP | 98,000 | $620,000 | 0.44% |
| HealthCor Management, L.P. | 455,000 | $2,880,000 | 0.36% |
| Financial Advocates Investment Management | 45,071 | $3,538,000 | 0.29% |
| PDT Partners, LLC | 262,767 | $1,663,000 | 0.25% |
| Monaco Asset Management SAM | 80,000 | $506,000 | 0.19% |
| Summit X, LLC | 103,424 | $651,000 | 0.19% |